Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8480339 | 8644640 | I | 8480339-3 | 20120603 | 20120621 | 20120630 | EXP | DE-TEVA-345239GER | TEVA | 61 | YR | F | Y | 60 | KG | 20120630 | MD | GERMANY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8480339 | 1020135273 | SS | HERCEPTIN | 1 | INTRAVENOUS | ||||||
| 8480339 | 1020135271 | PS | CARBOPLATIN | 1 | INTRAVENOUS | AUC 2 | 077269 | ||||
| 8480339 | 1020135270 | SS | DOXORUBICIN HCL | 1 | INTRAVENOUS | ||||||
| 8480339 | 1020135274 | SS | LAPATINIB | 1 | ORAL | 500 MILLIGRAM; | |||||
| 8480339 | 1020135272 | SS | TAXOL | 1 | INTRAVENOUS |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8480339 | 1020135273 | BREAST CANCER |
| 8480339 | 1020135271 | BREAST CANCER |
| 8480339 | 1020135270 | BREAST CANCER |
| 8480339 | 1020135274 | BREAST CANCER |
| 8480339 | 1020135272 | BREAST CANCER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8480339 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 8480339 | COLITIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8480339 | 1020135273 | 20120322 | 20120615 | ||
| 8480339 | 1020135271 | 20120322 | 20120615 | ||
| 8480339 | 1020135270 | 20120322 | 20120615 | ||
| 8480339 | 1020135274 | 20120322 | 20120615 | ||
| 8480339 | 1020135272 | 20120322 | 20120615 |